|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
TPH | BURROWS LAWRENCE B. | Director | Aug 02 | Sale | 31.48 | 7,677 | 241,672 | 86,891 | Aug 02 04:17 PM |
TPH | Burrows Lawrence B | Director | Mar 16 | Buy | 14.77 | 6,819 | 100,717 | 16,186 | Mar 18 05:26 PM |
WY | Burrows Lawrence B | Senior Vice President | Apr 02 | Option Exercise | 30.39 | 11,449 | 347,935 | 82,059 | Apr 02 06:04 PM |
WY | Burrows Lawrence B | Senior Vice President | Apr 02 | Sale | 31.50 | 11,449 | 360,644 | 70,610 | Apr 02 06:04 PM |
WY | Burrows Lawrence B | Senior Vice President | Apr 01 | Option Exercise | 30.39 | 11,379 | 345,808 | 81,989 | Apr 02 05:05 PM |
WY | Burrows Lawrence B | Senior Vice President | Apr 01 | Sale | 31.50 | 11,379 | 358,438 | 70,610 | Apr 02 05:05 PM |
WY | Burrows Lawrence B | Senior Vice President | Mar 20 | Option Exercise | 14.03 | 123,684 | 1,735,644 | 194,294 | Mar 21 02:51 PM |
WY | Burrows Lawrence B | Senior Vice President | Mar 20 | Sale | 31.03 | 123,684 | 3,838,323 | 70,610 | Mar 21 02:51 PM |
WY | Burrows Lawrence B | Senior Vice President | Feb 01 | Option Exercise | 24.29 | 136,520 | 3,316,619 | 165,590 | Feb 05 01:05 PM |
WY | Burrows Lawrence B | Senior Vice President | Feb 01 | Sale | 30.35 | 136,520 | 4,143,300 | 29,070 | Feb 05 01:05 PM |
WY | Burrows Lawrence B | Senior Vice President | Feb 22 | Option Exercise | 9.53 | 23,886 | 227,586 | 39,831 | Feb 22 08:13 PM |
WY | Burrows Lawrence B | Senior Vice President | Feb 22 | Sale | 24.05 | 23,886 | 574,551 | 15,945 | Feb 22 08:13 PM |
WY | Burrows Lawrence B | Senior Vice President | Feb 11 | Option Exercise | 14.88 | 69,540 | 1,034,506 | 85,485 | Feb 14 12:18 PM |
WY | Burrows Lawrence B | Senior Vice President | Feb 11 | Sale | 25.18 | 69,540 | 1,750,989 | 15,945 | Feb 14 12:18 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite